Efficacy of Intra-Articular Injection of Biofermentation-Derived High-Molecular Hyaluronic Acid in Knee Osteoarthritis: An Ultrasonographic Study

Cartilage - Tập 13 Số 1 - Trang 194760352210774 - 2022
Chia-Ling Lee1,2,3,4, Yingchun Wang5,6,7, Hsuan‐Ti Huang5,6,7, Chia‐Hsin Chen1,3,8, Kee‐Lung Chang9,10,4, Yin-Chun Tien11,5
1Department of Physical Medicine and Rehabilitation, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
2Department of Physical Medicine and Rehabilitation, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
3Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
4Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
5Department of Orthopedics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
6Department of Orthopedics, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
7Department of Orthopedics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
8Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan
9Department of Biochemistry, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
10Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
11College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Tóm tắt

Objective

The aim of this study is to evaluate the efficacy of intra-articular injection with HYAJOINT Plus, a biofermentation-derived, high-molecular hyaluronic acid (HA), on the progression of structural changes of cartilage in patients with knee osteoarthritis (OA) by using objectively promised ultrasonography (US) evaluation.

Design

In this prospective clinical trial, 56 OA patients completed the study. One single dose of injection of HYAJOINT Plus into the knee cavity was performed. The primary efficacy outcome measure for structural change of knee joint was evaluated by US using a semiquantitative grading system. Secondary efficacy outcome measures included Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total and subscale scores. All efficacy outcomes were measured at baseline and at first, third, and sixth month following treatment.

Results

There were significant US grade-improvement changes of cartilage between baseline and follow-up visits over medial femoral condyle and transverse overall evaluation at 3- and 6-month follow-ups, and over lateral femoral condyle, intercondylar notch, and medial longitudinal area at 6-month follow-up. The improved score change of WOMAC from baseline was significant at 1- and 3-month follow-ups in pain subscale, whereas score change from baseline was significant at 6-month follow-up in total score and all 3 subscale scores.

Conclusions

It was determined that significant improvement was found on cartilage by US after intra-articular injection with high-molecular weight, biological fermentation–derived HYAJOINT Plus. The semiquantitative grading system by US is a promising tool to identify the efficacy on cartilage band after interventions.

Từ khóa


Tài liệu tham khảo

10.1016/j.berh.2005.09.007

10.1016/S0140-6736(12)61729-2

10.1016/j.berh.2010.11.001

Woolf AD, 2003, Bull World Health Organ, 81

10.1136/annrheumdis-2019-216515

10.1016/S0140-6736(20)32230-3

10.1038/s41584-020-0378-4

10.1056/NEJMcp1903768

10.1016/j.joca.2020.10.006

10.1007/978-3-319-76735-2_6

10.1038/s41584-018-0123-4

10.1177/1947603511400184

10.1177/0363546512461902

10.1186/1471-2474-13-229

10.1016/j.arthro.2012.05.011

10.1097/PHM.0b013e3182aab72

10.1016/j.arthro.2013.07.264

10.1503/cmaj.120744

10.1016/S0033-8389(05)70125-1

Richardson ML, 1988, Radiol Clin North Am, 26, 63, 10.1016/S0033-8389(22)00967-8

Iagnocco A, 2010, Clin Exp Rheumatol, 28

10.1002/jum.14819

10.1016/j.joca.2007.07.013

10.1016/j.joca.2006.08.009

10.1016/j.apmr.2015.01.004

10.1136/ard.2005.037994

10.1136/ard.16.4.494

Bellamy N, 1988, J Rheumatol, 15

10.3389/fvets.2019.00192

10.3390/molecules25112649

10.2106/JBJS.RVW.17.00167

10.1177/0363546515609599

10.2106/JBJS.16.00469

10.3233/BMR-170950

10.1148/radiology.153.3.6387794

10.1016/j.joca.2012.01.016